Gastrodin, the active compound of the orchid Gastrodia elata, is a well-tolerated botanical with modest human support for migraine, tension headaches, and add-on blood pressure lowering. Its promoted uses for memory, mood, sleep, and brain protection rest mainly on laboratory and animal work. Evidence quality is low; long-term safety data are absent. (Full Review)

Protocol

Standard oral dose

300 mg

One to three times daily, as tablets or capsules

Dosing schedule

2–3 divided doses

Short ~1-hour half-life; split dosing gives more sustained exposure

Timing by goal

Evening or daytime

Evening dose for calming and sleep; morning and midday for daytime cognitive goals

Time to effect

Headache

Days to weeks

Migraine and tension headache with consistent use

Vertigo

Days to weeks

Dizziness episodes with consistent use

Brain aging

Months

Any neuroprotective benefit, if real; not directly felt

Benefits

Medium: Migraine relief; tension-type headache relief; blood pressure reduction

Low: Vertigo and dizziness; cognitive protection during cardiac surgery; sleep quality and sedation; anticonvulsant and seizure support; anxiety and mood support

Speculative: Neurodegenerative disease protection; general longevity and healthy aging

Contraindications

Known hypersensitivity to Gastrodia elata

Pregnancy or breastfeeding

Symptomatic low blood pressure (systolic below ~100 mmHg)

Key Interactions

Sedatives and central nervous system depressants (benzodiazepines, z-drugs, barbiturates, opioids, alcohol)

Blood-pressure-lowering drugs (ACE inhibitors, ARBs, calcium channel blockers, beta-blockers)

Additive supplements (magnesium, potassium, coenzyme Q10, garlic, valerian, kava, melatonin, L-theanine)

Over-the-counter drowsy antihistamines (diphenhydramine) and decongestants

Anticoagulant and antiplatelet agents (warfarin, aspirin, clopidogrel)

Surgery (discontinue at least 1–2 weeks before)

Risk & Side Effects

Medium: Hypersensitivity and allergic reactions

Low: Mild gastrointestinal and nervous system effects; excess sedation and drowsiness

Speculative: Hepatic effects with high-dose or prolonged herbal use; unknown long-term safety of isolated high-dose supplementation

Monitoring

Marker	Target	Why
Blood pressure	~110–120 / 70–80 mmHg	Gastrodin can modestly lower blood pressure, especially with antihypertensives
ALT / AST (liver enzymes)	ALT ~10–26 U/L; AST ~10–26 U/L	Screens for the theoretical hepatic effect of prolonged high-dose use
eGFR	>90 mL/min/1.73m²	Gastrodin distributes to and is cleared in part via the kidney; general safety reference
Heart rate / resting pulse	~55–70 bpm	Provides context for sedation and cardiovascular response

Cadence: Blood pressure at 1–2 weeks, then periodically; liver enzymes at around 3 months if using high doses long-term, then every 6–12 months

Qualitative Assessment

Headache or migraine frequency, duration, and intensity
Vertigo or dizziness episodes
Sleep quality and ease of falling asleep
Daytime calm, anxiety levels, and mood
Subjective mental clarity and daytime alertness, watching for over-sedation

Gastrodin for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment